Topical sirolimus 1% for benign lymphangiomatous papules after radiotherapy for endometrial and breast cancers: a report of three cases

Eur J Dermatol. 2021 Apr 1;31(2):252-254. doi: 10.1684/ejd.2021.4000.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Cutaneous
  • Aged
  • Antibiotics, Antineoplastic / administration & dosage
  • Antibiotics, Antineoplastic / therapeutic use*
  • Breast Neoplasms / radiotherapy*
  • Endometrial Neoplasms / radiotherapy*
  • Female
  • Humans
  • Lymphangioma / drug therapy*
  • Lymphangioma / etiology
  • Middle Aged
  • Radiotherapy / adverse effects
  • Sirolimus / administration & dosage
  • Sirolimus / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / etiology
  • Thoracic Wall
  • Vulvar Neoplasms / drug therapy*
  • Vulvar Neoplasms / etiology

Substances

  • Antibiotics, Antineoplastic
  • Sirolimus